BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27770449)

  • 1. Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.
    Tamm R; Mägi R; Tremmel R; Winter S; Mihailov E; Smid A; Möricke A; Klein K; Schrappe M; Stanulla M; Houlston R; Weinshilboum R; Mlinarič Raščan I; Metspalu A; Milani L; Schwab M; Schaeffeler E
    Clin Pharmacol Ther; 2017 May; 101(5):684-695. PubMed ID: 27770449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.
    Liu C; Yang W; Pei D; Cheng C; Smith C; Landier W; Hageman L; Chen Y; Yang JJ; Crews KR; Kornegay N; Karol SE; Wong FL; Jeha S; Sandlund JT; Ribeiro RC; Rubnitz JE; Metzger ML; Pui CH; Evans WE; Bhatia S; Relling MV
    Clin Pharmacol Ther; 2017 Mar; 101(3):373-381. PubMed ID: 27564568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacogenomics of thiopurine S-methyltransferase.
    Zhou S
    Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.
    Schaeffeler E; Jaeger SU; Klumpp V; Yang JJ; Igel S; Hinze L; Stanulla M; Schwab M
    Genet Med; 2019 Sep; 21(9):2145-2150. PubMed ID: 30728528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden.
    Zimdahl Kahlin A; Helander S; Skoglund K; Söderkvist P; Mårtensson LG; Appell ML
    Biochem Pharmacol; 2019 Jun; 164():263-272. PubMed ID: 31005613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity.
    Stocco G; Yang W; Crews KR; Thierfelder WE; Decorti G; Londero M; Franca R; Rabusin M; Valsecchi MG; Pei D; Cheng C; Paugh SW; Ramsey LB; Diouf B; McCorkle JR; Jones TS; Pui CH; Relling MV; Evans WE
    Hum Mol Genet; 2012 Nov; 21(21):4793-804. PubMed ID: 22846425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
    Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M
    Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.
    Yan L; Zhang S; Eiff B; Szumlanski CL; Powers M; O'Brien JF; Weinshilboum RM
    Clin Pharmacol Ther; 2000 Aug; 68(2):210-9. PubMed ID: 10976552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects.
    Rossi AM; Bianchi M; Guarnieri C; Barale R; Pacifici GM
    Eur J Clin Pharmacol; 2001 Apr; 57(1):51-4. PubMed ID: 11372592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.
    McLeod HL; Siva C
    Pharmacogenomics; 2002 Jan; 3(1):89-98. PubMed ID: 11966406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.
    Schwab M; Schäffeler E; Marx C; Fischer C; Lang T; Behrens C; Gregor M; Eichelbaum M; Zanger UM; Kaskas BA
    Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of novel defective thiopurine S-methyltransferase allelic variants.
    Garat A; Cauffiez C; Renault N; Lo-Guidice JM; Allorge D; Chevalier D; Houdret N; Chavatte P; Loriot MA; Gala JL; Broly F
    Biochem Pharmacol; 2008 Aug; 76(3):404-15. PubMed ID: 18602085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population.
    Spire-Vayron de la Moureyre C; Debuysere H; Mastain B; Vinner E; Marez D; Lo Guidice JM; Chevalier D; Brique S; Motte K; Colombel JF; Turck D; Noel C; Flipo RM; Pol A; Lhermitte M; Lafitte JJ; Libersa C; Broly F
    Br J Pharmacol; 1998 Oct; 125(4):879-87. PubMed ID: 9831928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population.
    Tamm R; Oselin K; Kallassalu K; Magi R; Anier K; Remm M; Metspalu A
    Clin Chem Lab Med; 2008; 46(7):974-9. PubMed ID: 18605963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease.
    Pashazadeh P; Marjani A; Asadi J; Khoshnia M
    Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.
    Stocco G; Crews KR; Evans WE
    Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
    Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
    J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic variants of the thiopurine S-methyltransferase deficiency in patients with ulcerative colitis and in healthy controls.
    Corominas H; Domènech M; González D; Diaz C; Roca M; García-González MA; Peña S; Baiget M
    Am J Gastroenterol; 2000 Sep; 95(9):2313-7. PubMed ID: 11007234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
    Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
    PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
    Stanulla M; Schaeffeler E; Flohr T; Cario G; Schrauder A; Zimmermann M; Welte K; Ludwig WD; Bartram CR; Zanger UM; Eichelbaum M; Schrappe M; Schwab M
    JAMA; 2005 Mar; 293(12):1485-9. PubMed ID: 15784872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.